Human Microbiome Market To Grow With Increasing Lifestyle Diseases During the Forecast Period
Advancing medical science is driving the growth of
Global Human Microbiome Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Human
Microbiome Market
By Product (Prebiotics, Probiotics, Medical Food, Supplements, Others), By
Application (Therapeutic, Diagnostic), By Disease (Autoimmune Disorder,
Digestive & Gastrointestinal Disorders, Oncology, Infectious, Metabolic
Disorders, Other Diseases), By Technology (Genomics, Proteomics, Metabolomics),
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy),
By Region, Competition Forecast & Opportunities, 2026”, the global human microbiome market is projected to grow at an
impressive CAGR in the forecast period, 2022-2026, owing to increasing
instances of respiratory diseases and on risk immunity of the population. With
the increasing urbanization, pollution level of the world is rapidly increasing
at a dramatic rate. Populations at large are being affected by the toxic
environment, poisonous air, polluted water, all factors that are influencing
the health conditions of the population thereby supporting the growth of the
market in the future five years. To improve the immunity, gut microbiome is
often responsible. The market is flooded with dairy and other food grade
products that contain probiotics and are considered to improve the patients’
immunity. Moreover, the rising number of patients suffering from problems like lung
disorder, respiratory disorder, diabetes, arthritis, gastrointestinal
disorders, and other neurological disorders are expected to boost the growth of
the market in the next five years.
Human microbiome is the average sum of all the microbiota that is in
human tissues and biofluids along with the anatomical sites correspondent to
the disease. These tissues and biofluids include, skin tissues, mammary glands,
placenta, seminal fluids, uterus, ovarian follicles, lungs, saliva, oral mucosa,
gastrointestinal tract, etc. Altering of the human microbiome can help in
eradicating the lifestyle diseases.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Human Microbiome Market"
https://www.techsciresearch.com/report/human-microbiome-market/7430.html
The global human microbiome market is segmented by
product, application, diseases, technology, distribution channel, competitional
landscape, and regional distribution. Based on application, the market is
further bifurcated into therapeutic, and diagnostic. Therapeutics application
is anticipated to hold the largest market share in the future five years. On
the account of increasing instances of lifestyle diseases, better and efficient
healthcare facility and medicine is in demand thus driving the growth of the
market segment of the human microbiome market. Technological advancements are
made in the therapeutic sector and increasing research and development is
expected to strengthen the market growth. Moreover, the COVID-19 pandemic
spread has created a new wave of urgency for the effective therapeutics toward
the infectious diseases. Diagnostics segment is also anticipated to hold
significant share of the market owing to a surge in the demand of the early and
effective diagnostic for the health concerns people are facing at large. The
late discovery and no proper method of identifying the virus spread has led to
million deaths worldwide, therefore, increasing demand for the fast and
confirmed diagnostic is anticipated to drive the market share.
Major companies operating in the market are Enterome
Bioscience SA, Yakult Honsha Co. Ltd., Dupont Inc., Seres Therapeutics Inc., Synthetic
Biologics Inc., Second Genome Inc., uBiome Inc., Rebiotix Inc., Microbiome
Therapeutics LLC, Osel Inc., Merck and Co., Inc., AOBiome LLC, Vithera
Pharmaceuticals Inc., AG Metabiomics Corporation, Ferring Pharmaceuticals SA,
among others.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7430
Customers can also request for
10% free customization on this report.
“United States has
rapidly increasing number of obese and diabetic people, therefore, North
America is a promising market for the future of human microbiome projects.
Moreover, these diseases are anticipated to increase in the upcoming five
years. The improving healthcare industry of the region is a major driver for
the growth of the market shares in the future. Consistent research and
development are going on over the human microbiome. Government aid towards the
research and development is going to be needed for the rapid growth of the
market. New market players are advised to enter the market with a collaboration
or the partnerships and financial investments in the research and development
related to human microbiome. The recent wake of COVID-19 pandemic has alerted
the world about the need of consistent and definite research to develop their
therapeutics and diagnosis for the efficient and well developed health care,
thus the market is only anticipated to grow,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based Global management consulting
firm.
“Global Human Microbiome
Market By Product (Prebiotics, Probiotics, Medical Food, Supplements, Others), By
Application (Therapeutic, Diagnostic), By Disease (Autoimmune Disorder,
Digestive & Gastrointestinal Disorders, Oncology, Infectious, Metabolic
Disorders, Other Diseases), By Technology (Genomics, Proteomics, Metabolomics),
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online
Pharmacy), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the
future growth potential of global human microbiome and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global human microbiome market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/